Bio-Techne Built a $1.2 Billion Lab-Supply Machine - Then One Bad Bet Clarified the Whole Business

The Minneapolis life-sciences supplier turned a catalog of repeat-purchase reagents into a $1.2 billion business. Its best lesson is not the pending $11.3 billion exit - it is how one expensive diagnostics detour forced the portfolio back toward tools that scale.